SCHEMBL5659501

SCHEMBL5659501

COc1ccccc1NC(=O)OCCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
ADRA1D P25100 2/20 0.57
ADRA1A P35348 2/20 0.57
ADRA1B P35368 2/20 0.57
DRD2 P14416 4/20 0.56
ALDH1A1 P00352 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
HRH3 Q9Y5N1 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
USP2 O75604 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HTR1A P08908 1/20 0.50
DRD1 P21728 1/20 0.50
HTR2A P28223 1/20 0.50
DRD3 P35462 1/20 0.50
ABCB1 P08183 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5654284 0.94 KDM4E (0.60) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL5657183 0.91 DRD2 (0.55) ADRA1DADRA1AADRA1BDRD2HRH3
SCHEMBL5656355 0.90 ALDH1A1 (0.70) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL5656283 0.87 ADRA1D (0.54) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL5655841 0.86 ADRA1A (0.71) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL5657864 0.86 L3MBTL1 (0.59) ADRA1DADRA1AADRA1BALDH1A1NPSR1
SCHEMBL5657438 0.85 HRH3 (0.56) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL5657914 0.84 POLB (0.50) KDM4EDRD2HRH3DRD3
SCHEMBL5656326 0.84 ALDH1A1 (0.54) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL5655927 0.83 ADRA1A (0.62) ADRA1DADRA1AADRA1BDRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C KDM4E 512/4885ADRA1D 265/4885ADRA1A 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.